bioAffinity sells warrants in private placement for up to 980,072 shares

bioAffinity Technologies priced warrants covering 980,072 common shares at a $6.122 exercise price, alongside a registered direct sale. The transactions are expected to generate about $4 million in gross proceeds, with closing targeted for about Oct. 9, 2026.